newsModerna and ROVI face further particulate problems with Spikevax®14 April 2022 | By Hannah Balfour (European Pharmaceutical Review)A lot of Moderna’s Spikevax® vaccine is being recalled due to particulates, just six months after previous contamination concerns were supposedly solved.
newsEU secures 80 million doses of Moderna COVID-19 vaccine27 November 2020 | By Victoria Rees (European Pharmaceutical Review)The European Commission and Moderna have agreed that the company will supply at least 80 million doses of mRNA-1273, the company's COVID-19 vaccine candidate.